Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Synovitis? 162 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 162 reports of Synovitis have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 1.8% of all adverse event reports for CYCLOBENZAPRINE.

162
Reports of Synovitis with CYCLOBENZAPRINE
1.8%
of all CYCLOBENZAPRINE reports
160
Deaths
94
Hospitalizations

How Dangerous Is Synovitis From CYCLOBENZAPRINE?

Of the 162 reports, 160 (98.8%) resulted in death, 94 (58.0%) required hospitalization, and 96 (59.3%) were considered life-threatening.

Is Synovitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOBENZAPRINE. However, 162 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Synovitis?

METHOTREXATE (11,451) ADALIMUMAB (9,965) ABATACEPT (9,783) ETANERCEPT (9,599) TOCILIZUMAB (9,428) HYDROXYCHLOROQUINE (9,123) LEFLUNOMIDE (8,889) RITUXIMAB (7,956) INFLIXIMAB (7,856) SULFASALAZINE (7,566)

Which CYCLOBENZAPRINE Alternatives Have Lower Synovitis Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Synovitis Reports All Drugs Causing Synovitis CYCLOBENZAPRINE Demographics